Portfolio holdings of Hillman Value Fund. Hillman Value Fund stock picks:. Stock Holdings page.
Hillman Value Fund
i
Investment Strategy
In seeking to achieve its objective, the Fund invests primarily in common stocks of U.S. companies which Hillman Capital Management, Inc. (the “Advisor”) believes have qualitative and quantitative competitive advantages, as described below, and have temporarily fallen out of favor for reasons that are considered non-recurring or short-term; whose value is not currently well known; or whose value is not fully recognized by the public. As a matter of investment policy, the Fund will invest so that, under normal circumstances, at least 80% of the value of its total net assets is invested in publicly traded equity securities of various issuers, including common stock, preferred stock, and securities that may be converted into or are exercisable for common or preferred stock.
In selecting investments for the Fund, the Advisor first looks at qualitative measures of a company. Qualitative measures of a company include:
- dominance in a particular industry or niche market;
- management style and adaptability;
- strength of pricing and purchasing power;
- barriers to industry competition;
- strength of brand or franchise with commensurate brand loyalty; and
- quality of products and services.
If certain companies meet most or all of the qualitative measures, the Advisor then seeks to identify which of those companies possess certain positive quantitative measures and which of those companies the Advisor feels show superior prospects for growth. The Advisor may make investments without regard to market capitalization. These companies may, in the view of the Advisor, exhibit positive changes such as a promising new product, new distribution strategy, new manufacturing technology, new management team, or new management philosophy. These companies may also be responsible for technological breakthroughs and/or unique solutions to
market needs.
The quantitative measures of a company include:
- price-to-book ratio;
- present value of discounted projected cash flows;
- balance sheet strength;
- price-to-sales ratio;
- and price-to-earnings ratio.
The Advisor allocates a target percentage of total portfolio value to each security it purchases. Under normal market conditions, the Advisor intends to be fully invested in equities with the portfolio comprised of approximately 20 stocks. From time to time, the Fund may also focus the Fund’s assets in securities of one or more particular sectors of the economy and may at times invest more than 25% of the Fund’s net assets in a particular sector, such as the financial, healthcare, retail, and technology sectors. The Advisor may sell a portfolio holding if the Advisor believes that the price of the security is overvalued or to rebalance the security to the Advisor’s targeted percentage of total portfolio value for that security.
In seeking to achieve its objective, the Fund invests primarily in common stocks of U.S. companies which Hillman Capital Management, Inc. (the “Advisor”) believes have qualitative and quantitative competitive advantages, as described below, and have temporarily fallen out of favor for reasons that are considered non-recurring or short-term; whose value is not currently well known; or whose value is not fully recognized by the public. As a matter of investment policy, the Fund will invest so that, under normal circumstances, at least 80% of the value of its total net assets is invested in publicly traded equity securities of various issuers, including common stock, preferred stock, and securities that may be converted into or are exercisable for common or preferred stock.
In selecting investments for the Fund, the Advisor first looks at qualitative measures of a company. Qualitative measures of a company include:
- dominance in a particular industry or niche market;
- management style and adaptability;
- strength of pricing and purchasing power;
- barriers to industry competition;
- strength of brand or franchise with commensurate brand loyalty; and
- quality of products and services.
If certain companies meet most or all of the qualitative measures, the Advisor then seeks to identify which of those companies possess certain positive quantitative measures and which of those companies the Advisor feels show superior prospects for growth. The Advisor may make investments without regard to market capitalization. These companies may, in the view of the Advisor, exhibit positive changes such as a promising new product, new distribution strategy, new manufacturing technology, new management team, or new management philosophy. These companies may also be responsible for technological breakthroughs and/or unique solutions to
market needs.
The quantitative measures of a company include:
- price-to-book ratio;
- present value of discounted projected cash flows;
- balance sheet strength;
- price-to-sales ratio;
- and price-to-earnings ratio.
The Advisor allocates a target percentage of total portfolio value to each security it purchases. Under normal market conditions, the Advisor intends to be fully invested in equities with the portfolio comprised of approximately 20 stocks. From time to time, the Fund may also focus the Fund’s assets in securities of one or more particular sectors of the economy and may at times invest more than 25% of the Fund’s net assets in a particular sector, such as the financial, healthcare, retail, and technology sectors. The Advisor may sell a portfolio holding if the Advisor believes that the price of the security is overvalued or to rebalance the security to the Advisor’s targeted percentage of total portfolio value for that security.
Period: Q1 2026
Portfolio date: 31 Mar 2026
No. of stocks: 37
Portfolio value: $79,748,000
| History | Stock | % of Portfolio |
RecentActivity | Shares | ReportedPrice* | Value | Current Price |
+/-Reported Price |
52Week Low |
52Week High |
|
| ≡ | VZ - Verizon Communications | 3.59 | 57,000 | $50.19 | $2,861,000 | $45.98 | -8.39% | $10.26 | $50.91 | ||
| ≡ | BMY - Bristol-Myers Squibb | 3.53 | Reduce 11.45% | 46,400 | $60.65 | $2,814,000 | $58.80 | -3.05% | $41.46 | $62.24 | |
| ≡ | PFE - Pfizer Inc. | 3.26 | 92,700 | $28.08 | $2,603,000 | $26.80 | -4.56% | $20.73 | $28.75 | ||
| ≡ | BIIB - Biogen Inc. | 3.24 | 14,100 | $183.33 | $2,585,000 | $190.07 | 3.68% | $115.25 | $202.41 | ||
| ≡ | IFF - International Flavors & Fragrances Inc. | 3.21 | 35,300 | $72.55 | $2,561,000 | $71.17 | -1.90% | $58.43 | $83.95 | ||
| ≡ | STZ - Constellation Brands | 3.08 | 16,400 | $150.00 | $2,460,000 | $156.88 | 4.59% | $125.63 | $192.99 | ||
| ≡ | WBD - Warner Bros. Discovery Inc. | 3.02 | Reduce 19.32% | 87,700 | $27.46 | $2,408,000 | $27.33 | -0.47% | $8.06 | $30.00 | |
| ≡ | CMCSA - Comcast Corp. | 2.99 | 83,077 | $28.71 | $2,385,000 | $29.37 | 2.30% | $23.62 | $33.03 | ||
| ≡ | USB - U.S. Bancorp | 2.97 | Reduce 16.51% | 45,500 | $52.00 | $2,366,000 | $56.60 | 8.85% | $37.66 | $60.56 | |
| ≡ | DD - DuPont de Nemours Inc. | 2.95 | Reduce 25.40% | 51,400 | $45.80 | $2,354,000 | $45.98 | 0.39% | $24.68 | $52.45 | |
| ≡ | ZBH - Zimmer Biomet Holdings | 2.93 | 25,800 | $90.43 | $2,333,000 | $93.04 | 2.89% | $84.36 | $107.45 | ||
| ≡ | TSM - Taiwan Semiconductor S.A. | 2.88 | Reduce 21.84% | 6,800 | $337.94 | $2,298,000 | $387.44 | 14.65% | $154.11 | $389.11 | |
| ≡ | AKAM - Akamai Technologies Inc. | 2.84 | Reduce 42.90% | 19,700 | $114.87 | $2,263,000 | $97.11 | -15.46% | $69.78 | $121.12 | |
| ≡ | CVS - CVS Health Corp. | 2.84 | 31,500 | $71.81 | $2,262,000 | $76.43 | 6.43% | $56.79 | $84.46 | ||
| ≡ | GSK - GSK plc | 2.84 | Reduce 25.99% | 41,000 | $55.20 | $2,263,000 | $55.70 | 0.91% | $34.47 | $61.20 | |
| ≡ | WST - West Pharmaceutical Services | 2.80 | Reduce 7.29% | 8,900 | $250.67 | $2,231,000 | $274.41 | 9.47% | $199.19 | $321.79 | |
| ≡ | HSY - Hershey Co. | 2.76 | Reduce 23.74% | 10,600 | $207.92 | $2,204,000 | $188.65 | -9.27% | $146.80 | $239.48 | |
| ≡ | UPS - United Parcel Service | 2.75 | Reduce 16.79% | 22,300 | $98.39 | $2,194,000 | $105.30 | 7.02% | $79.49 | $120.73 | |
| ≡ | KHC - Kraft Heinz Co. | 2.69 | 95,300 | $22.49 | $2,143,000 | $21.89 | -2.67% | $21.04 | $28.59 | ||
| ≡ | KMX - CarMax Inc. | 2.67 | Reduce 19.09% | 51,300 | $41.58 | $2,133,000 | $39.58 | -4.81% | $30.26 | $71.99 | |
| ≡ | BF.B - Brown-Forman Corp. | 2.63 | 79,400 | $26.44 | $2,099,000 | $28.53 | 7.90% | $22.61 | $35.01 | ||
| ≡ | DIS - Walt Disney Co. | 2.59 | Reduce 8.15% | 21,400 | $96.40 | $2,063,000 | $104.82 | 8.73% | $85.82 | $123.85 | |
| ≡ | ORCL - Oracle Corp. | 2.58 | Buy | 14,000 | $147.14 | $2,060,000 | $187.50 | 27.43% | $129.69 | $343.01 | |
| ≡ | CAG - Conagra Brands Inc. | 2.51 | 127,100 | $15.72 | $1,998,000 | $14.53 | -7.57% | $14.04 | $23.79 | ||
| ≡ | TROW - T. Rowe Price Group | 2.51 | 22,200 | $90.14 | $2,001,000 | $100.24 | 11.20% | $81.80 | $113.69 | ||
| ≡ | UNH - United Health Group Inc. | 2.51 | 7,400 | $270.54 | $2,002,000 | $353.52 | 30.67% | $229.79 | $426.81 | ||
| ≡ | NKE - NIKE Inc. | 2.50 | 37,800 | $52.83 | $1,997,000 | $45.68 | -13.53% | $42.09 | $78.72 | ||
| ≡ | FISV - Fiserv Inc. | 2.46 | 35,100 | $55.81 | $1,959,000 | $63.26 | 13.35% | $52.91 | $221.50 | ||
| ≡ | BDX - Becton Dickinson | 2.43 | 12,300 | $157.24 | $1,934,000 | $155.65 | -1.01% | $125.44 | $186.16 | ||
| ≡ | BA - Boeing Co. | 2.40 | Reduce 12.73% | 9,600 | $199.06 | $1,911,000 | $231.28 | 16.19% | $169.00 | $254.35 | |
| ≡ | BAX - Baxter International Inc. | 2.39 | 113,200 | $16.80 | $1,902,000 | $18.31 | 8.99% | $15.73 | $32.24 | ||
| ≡ | MSFT - Microsoft Corp. | 2.23 | 4,800 | $370.21 | $1,777,000 | $432.92 | 16.94% | $356.28 | $552.24 | ||
| ≡ | DEO - Diageo ADR | 2.18 | 23,300 | $74.46 | $1,735,000 | $79.95 | 7.37% | $71.73 | $112.57 | ||
| ≡ | CPB - Campbell's Co. | 2.12 | 75,900 | $22.27 | $1,690,000 | $20.82 | -6.51% | $19.76 | $35.77 | ||
| ≡ | CRM - Salesforce.com | 2.11 | 9,000 | $186.67 | $1,680,000 | $189.80 | 1.68% | $163.52 | $293.86 | ||
| ≡ | EL - Estee Lauder Cos. | 2.03 | Reduce 13.46% | 22,500 | $71.78 | $1,615,000 | $76.66 | 6.80% | $55.30 | $121.25 | |
| ≡ | ADBE - Adobe Inc. | 2.01 | 6,600 | $243.03 | $1,604,000 | $255.94 | 5.31% | $224.13 | $422.95 |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
Sector % analysis
| Health Care | 25.93 | |
| Consumer Staples | 20.66 | |
| Consumer Discretionary | 13.77 | |
| Information Technology | 9.28 | |
| Technology | 7.83 | |
| Materials | 6.16 | |
| Financials | 5.48 | |
| Industrials | 5.15 | |
| Communication Services | 3.59 | |
| Consumer Goods | 2.18 |